1H-MR spectroscopic imaging for characterization of prostate tumors: Proof of principle of imaging the polyamine concentration at a 7 Tesla MRI

1H-MR spectroscopic imaging for characterization of prostate tumors: Proof of principle of imaging the polyamine concentration at a 7 Tesla MRI - 7T MRS to characterize prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38285

Enrollment

Registered

2010-07-16

Start date

2011-03-31

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polyamines Prostate cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: prostate cancer scheduled for a radiotherapy treatment

Exclusion criteria

Exclusion criteria: Patient who meet the UMC Utrech 7T MRS exlusion criteria

Design outcomes

Secondary

Measure	Time frame
Study the concentration ratios of polyamines relative to creatine, choline and citrate that occur in prostate tumors and healthy parts of the prostate.	—

Primary

Measure	Time frame
Obtain proof of principle of the imaging of the polyamine concentration in patients with prostate cancer, using 1H-MR spectroscopic imaging at 7T.	—

Countries

Netherlands

Outcome results